Peer-reviewedLicence not statedBiomedical Reports9 Oct 2026

Assessment of a direct fluorescence-based cell-free DNA assay for evaluating the extent of metastatic dissemination: An exploratory study

Jae-Joon Kim¹
Yangjeong Lee²
Yun Jeong Hong³
Kwonoh Park⁴

4 affiliations

¹Division of Hematology and Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do 50612, Republic of Korea
²Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do 50612, Republic of Korea
³Department of Neurology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 11765, Republic of Korea
⁴Division of Hematology & Medical Oncology, Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Gyeonggi-do 10326, Republic of Korea

Read full text PDF DOI Cite

Early Assessment of Circulating Tumor Cells and Their PD-L1 Expression as Predictive Biomarkers in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: An Exploratory Study
Emmanuel Grolleau, David Barthelemy, Aurélien Millet +10
ImmunoTargets and Therapy27 Oct 2026Peer-reviewedCC BY-NC 4.0Full textOncologyPMC
Pseudo-peritoneal carcinomatosis: extensive endosalpingiosis mimicking metastatic dissemination in gastric cancer : a case report and literature review.
Saida Sakhri, Eya Ghorbeli, Aya Khemir +3
BMC gastroenterology1 Aug 2026Peer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCPMC
From epithelial-mesenchymal transition to liquid biopsy: mechanisms of gastric cancer metastatic dissemination and circulating biomarker-guided anti-recurrence strategies
Tianlu Chu, Peipei Yang, Peng Shu
Frontiers in Oncology9 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiers
Assessment of Dissemination in Time in Multiple Sclerosis Using a Single 3D T2-FLAIR magnetic resonance imaging Radiomic Signature
E. G. GUZMAN, A. Casajuana-Larque, M. Alberich +9
medRxiv29 Oct 2026PreprintAll rights reservedFull textNeurologymedRxiv
Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis.
Daichi Watanabe, Hironori Fujii, Yuto Miura +11
International journal of colorectal disease4 Aug 2026Peer-reviewedCC BYFull textOncologyEurope PMCPMC

Cite

BibTeX RIS

BibTeX

@article{kim2026assessment,
  title = {{Assessment of a direct fluorescence-based cell-free DNA assay for evaluating the extent of metastatic dissemination: An exploratory study}},
  author = {Jae-Joon Kim and Yangjeong Lee and Yun Jeong Hong and Kwonoh Park},
  journal = {Biomedical Reports},
  year = {2026},
  month = oct,
  doi = {10.3892/br.2026.2214},
  url = {https://doi.org/10.3892/br.2026.2214},
}

RIS

TY  - JOUR
TI  - Assessment of a direct fluorescence-based cell-free DNA assay for evaluating the extent of metastatic dissemination: An exploratory study
AU  - Jae-Joon Kim
AU  - Yangjeong Lee
AU  - Yun Jeong Hong
AU  - Kwonoh Park
PY  - 2026
DA  - 2026/10/09
JO  - Biomedical Reports
DO  - 10.3892/br.2026.2214
UR  - https://doi.org/10.3892/br.2026.2214
SN  - 2049-9434
SN  - 2049-9442
ER  -

Related

Cite